Use of inotuzumab‐ozogamicin in a child with Down syndrome and refractory B‐cell precursor acute lymphoblastic leukemia
Laura Murillo(Centro de Salud Casa del Barco), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Pablo Velasco(Vall d'Hebron Hospital Universitari), José Luís Dapena(Hospital Materno-Infantil)
Cited by 9
Related Papers
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
|Haematologica|2014|389
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
|Journal of Clinical Oncology|2020|333
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study
|Journal of Allergy and Clinical Immunology|2017|318